| Literature DB >> 28641506 |
Robert R Maronpot1, Abraham Nyska2, Sean P Troth3, Kathleen Gabrielson4, Polina Sysa-Shah4, Vyacheslav Kalchenko5, Yuri Kuznetsov5, Alon Harmelin5, Yael S Schiffenbauer6, David Bonnel7, Jonathan Stauber7, Yuval Ramot8.
Abstract
Available imaging systems for use in preclinical toxicology studies increasingly show utility as important tools in the toxicologic pathologist's armamentarium, permit longitudinal evaluation of functional and morphological changes in tissues, and provide important information such as organ and lesion volume not obtained by conventional toxicology study parameters. Representative examples of practical imaging applications in toxicology research and preclinical studies are presented for ultrasound, positron emission tomography/single-photon emission computed tomography, optical, magnetic resonance imaging, and matrix-assisted laser desorption ionization-imaging mass spectrometry imaging. Some of the challenges for making imaging systems good laboratory practice-compliant for regulatory submission are presented. Use of imaging data on a case-by-case basis as part of safety evaluation in regulatory submissions is encouraged.Entities:
Keywords: CT; MALDI imaging; MRI; PET; optical imaging; preclinical imaging; toxicologic pathology; ultrasound imaging
Mesh:
Year: 2017 PMID: 28641506 DOI: 10.1177/0192623317710014
Source DB: PubMed Journal: Toxicol Pathol ISSN: 0192-6233 Impact factor: 1.902